Jobs / United States / Glaxosmithkline LLC
SERM Medical Director
Glaxosmithkline LLC · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles8 certified filings for “Principal Scientist” (Medical Scientists, Except Epidemiologists) in PA: $98k–$110k, median $98k. Most were filed at wage level I (63%) — 1 lottery entry, ≈15% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people’s lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients’ needs and have the highest probability of success. We’re uniting science, technology, and talent to get ahead of disease together. Find out more: Our approach to R&D Position Summary Provides medical and scientific leadership in the safety evaluation and risk management of GSK’s Immunology assets in clinical development. Responsible for the interpretation of safety data, identification and escalation of safety signals, and delivery of clear, evidence-based recommendations to support benefit–risk decisions. This role contributes to global governance and plays a critical part in protecting patient safety and shaping the safety profile of innovative medicines. Key Responsibilities Scientific / Medical & Pharmacovigilance Expertise • Lead pharmacovigilance and risk management activities for assigned immunology assets and clinical trials • Define and drive strategy for the evaluation and management of safety issues across the clinical development lifecycle including early-phase development • Analyse and interpret clinical data, literature, and emerging evidence to identify and assess safety signals • Provide expert medical input into the safety components of global regulatory submissions • Apply sound clinical judgement to complex and sometimes conflicting data sets to inform benefit–risk decisions • Ensure timely escalation of safety concerns in line with governance processes Matrix Leadership & Cross-functional Collaboration • Represent Safety on cross-functional Clinical Matrix and Project Teams • Lead cross-functional teams to address urgent and complex product safety issues • Actively contribute to and, where appropriate, lead Safety Review Teams (SRTs) • Build strong, collaborative relationships across functions and geographies • Coach and mentor colleagues, contributing to capability development within the organisation • Ensure effective communication and alignment with Safety Leads, senior SERM leadership, and key stakeholders Communication, Influence & Governance • Lead presentations on safety issues and recommendations to senior governance committees • Influence decision-making through clear, credible, and evidence-based communication • Represent GSK in interactions with regulatory authorities, external experts, and partners • Contribute to the development of safety strategy for clinical programmes and broader SERM activities • Identify opportunities to improve processes, drive innovation, and enhance operational effectiveness • Operate with strong awareness of the internal and external regulatory and scientific environment Why Join Us? This is an opportunity to play a pivotal role in advancing GSK’s immunology pipeline, with direct impact on patient safety and global health outcomes. You will: • Shape the safety strategy of innovative Immunology medicines • Engage with senior governance and influence key development decisions • Work within a highly collaborative, global matrix environment • Contribute to scientific excellence and continuous improvement in safety science Basic Qualifications • Medical degree (or eligibility to practise in the UK) and relevant clinical experience • Completion of formal postgraduate clinical train